Your Article Summary
Mirabilis Raises $4 Million to Commercialize Non-Invasive Treatment of Uterine Fibroids
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/30/06
Mirabilis Medica, Inc., a privately-held medical device company, announced the initial closing of a $4 million Series A financing that will be used to complete development, testing and introduction of its image-guided High Intensity Focused Ultrasound (HIFU) system for treatment of gynecological diseases. The financing was co-led by Charter Life Sciences of Palo Alto and vSpring Capital of Salt Lake City
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09
Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
Article Search
Sponsor


See Latest Articles


